BioSort
PrivateLast Round
Early Funding
Feb 23, 2026
Total Funding Raised
$10.44M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioSort operates in Frontier & Industrial Tech and is based in Norway. Its latest recorded funding round was an Early Funding round in February 2026.
BioSort is an aquaculture technology company that develops sensor-based equipment and AI-driven solutions to monitor fish health and improve sustainability in the aquaculture industry.
Sector
Frontier & Industrial Tech
Verticals
Computer Vision, Sensors, Environmental Monitoring, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioSort Comparables
Compare BioSort with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fishency Innovation AS | 90% | |
| Stingray Marine Solutions | 86% | |
| OptoScale AS | 79% |
For institutional investors. Book with your work email.
BioSort Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioSort Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ichthus Venture Capital | Early Funding |
| Grieg Kapital | Early Funding |
| Farvatn | Early Funding |
| Futurum Ventures | Early Funding |
| Hatch Blue | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2026
Partnered with Rede People for recruitment services.
- Jun 20, 2026
Monthly visitors grew 775% MoM to 3.2K.
For institutional investors. Book with your work email.
BioSort Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioSort's valuation, stock price, and market status.
Is BioSort a public or private company?
BioSort is a private company.
What is the current stock price of BioSort?
BioSort is a private company, so its shares have no public market price. Caplight tracks BioSort's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioSort worth (valuation)?
Valuation information for BioSort is not publicly available.
Can I buy BioSort stock?
BioSort shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioSort's last funding round?
BioSort's most recent funding round was Early Funding on February 23, 2026.
Who are the main investors in BioSort?
Key investors in BioSort include Ichthus Venture Capital, Grieg Kapital, Farvatn, Futurum Ventures, Hatch Blue.
Will BioSort IPO soon?
No public IPO plans have been announced for BioSort.
How can I track BioSort secondary market activity?
Caplight tracks bids, offers, and trades in BioSort's shares on secondary markets.